DF-003(Drug Farm)
- Generic Name
- DF-003(Drug Farm)
Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
- First Posted Date
- 2024-05-02
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)
- Target Recruit Count
- 12
- Registration Number
- NCT06395285
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
🇺🇸Duke Eye Center - Duke University Hospital, Durham, North Carolina, United States
🇺🇸John A. Moran Eye Center - University of Utah Health, Salt Lake City, Utah, United States
Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects
Phase 1
Active, not recruiting
- Conditions
- HealthySafety and Tolerability
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-08-18
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)
- Target Recruit Count
- 96
- Registration Number
- NCT05997641
- Locations
- 🇺🇸
Altasciences Clinical Los Angeles, Inc, Cypress, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath